Thymidilate Synthase and P53 Primary Tumour Expression as Predictive Factors for Advanced Colorectal Cancer Patients

British Journal of Cancer - United Kingdom
doi 10.1054/bjoc.1999.0964
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Serum Anti-P53 Antibody as a Tumour Marker for Colorectal Cancer Screening

ecancermedicalscience
Cancer ResearchOncology
2015English

Thymidylate Synthase Expression as a Predictive Biomarker of Pemetrexed Sensitivity in Advanced Non-Small Cell Lung Cancer

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2015English

PET Scans as a Predictive Marker of Survival in Advanced Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2015English

Influence of Primary Tumour and Patient Factors on Survival in Patients Undergoing Curative Resection and Treatment for Liver Metastases From Colorectal Cancer

BJS open
Surgery
2019English

Expression of P53 and DR5 in Normal and Malignant Tissues of Colorectal Cancer: Correlation With Advanced Stages

Oncology Reports
MedicineCancer ResearchOncology
2011English

Predictive Value of C-erbB-2, P53, Cathepsin-D and Histology of the Primary Tumour in Metastatic Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
1997English

Predictive and Prognostic Value of 18f-Fluorodeoxyglucose Uptake Combined With Thymidylate Synthase Expression in Patients With Advanced Non-Small Cell Lung Cancer

Scientific Reports
Multidisciplinary
2019English

Predictive Factors for the Efficacy of the Second Taxane Treatment in Patients With Advanced Cancer

Cancer Management and Research
Oncology
2018English

The Predictive Effect of Primary Tumour Location in the Treatment of Metastatic Colorectal Cancer: A Canadian Consensus Statement

Current Oncology
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy